Phase I Study of RiMO-401 With Radiation in Advanced Tumors

NCT06182579 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped slow enrollment

Conditions

Advanced Solid Tumor
Intratumoral Injection

Interventions

DRUG: RiMO-401

Sponsor

Coordination Pharmaceuticals, Inc.